Search by Drug Name or NDC

    NDC 00115-1757-03 Cyproheptadine Hydrochloride 4 mg/1 Details

    Cyproheptadine Hydrochloride 4 mg/1

    Cyproheptadine Hydrochloride is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Amneal Pharmaceuticals of New York LLC. The primary component is CYPROHEPTADINE HYDROCHLORIDE.

    Product Information

    NDC 00115-1757
    Product ID 0115-1757_dd0666c7-8d08-4a7d-9afa-11980af71d73
    Associated GPIs 41500020100305
    GCN Sequence Number 004011
    GCN Sequence Number Description cyproheptadine HCl TABLET 4 MG ORAL
    HIC3 Z2P
    HIC3 Description ANTIHISTAMINES - 1ST GENERATION
    GCN 15811
    HICL Sequence Number 001672
    HICL Sequence Number Description CYPROHEPTADINE HCL
    Brand/Generic Generic
    Proprietary Name Cyproheptadine Hydrochloride
    Proprietary Name Suffix n/a
    Non-Proprietary Name Cyproheptadine Hydrochloride
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 4
    Active Ingredient Units mg/1
    Substance Name CYPROHEPTADINE HYDROCHLORIDE
    Labeler Name Amneal Pharmaceuticals of New York LLC
    Pharmaceutical Class n/a
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA040537
    Listing Certified Through 2024-12-31

    Package

    NDC 00115-1757-03 (00115175703)

    NDC Package Code 0115-1757-03
    Billing NDC 00115175703
    Package 1000 TABLET in 1 BOTTLE, PLASTIC (0115-1757-03)
    Marketing Start Date 2015-07-29
    NDC Exclude Flag N
    Pricing Information N/A